Theart v Theart and Others (9381/2022) [2023] ZAWCHC 130 (1 June 2023)
The court found that the failure to notify Millivent 24CC, a shareholder, of the 28 October 2021 meeting rendered the resolution appointing the first respondent as director of the third respondent invalid. Section 62 of the Companies Act requires notice to all shareholders, and no waiver or ratification occurred. The subsequent resolution to remove the applicant as director was also invalid, as the applicant was not afforded a reasonable opportunity to respond in person, contrary to section 71(4) of the Companies Act. The respondents' reliance on estoppel was rejected, as estoppel cannot cure non-compliance with statutory requirements enacted in the public interest. The...
- Citation
- [2023] ZAWCHC 130
- Parties
- Applicant: Tiron Theart; Respondent: Rene Theart; Respondent: Nongenzeni Eunice Mbena; Respondent: Lorcom Thirteen (Pty) Ltd; Respondent: Frederick Woest Edwards N.O.; Respondent: Companies and Intellectual Property Commission
- Court
- Western Cape High Court, Cape Town
- Jurisdiction
- South Africa
- Judgment Date
- 1 June 2023
- Case Number
- 9381/2022
- Procedural Posture
- Review Application / Judgment
- Outcome
- The application was granted; the resolutions appointing the first respondent as director and removing the applicant as director were declared null and void. The counter-application was dismissed. Costs were awarded against the first and second respondents.
- Judges
- Le Roux
- Legal Topics
- Companies Act Appointment and Removal of Directors, Shareholder Meeting Notice Requirements, Delinquent Director Application, Estoppel in Corporate Law
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Tiron Theart
Applicant
Rene Theart
Respondent
Nongenzeni Eunice Mbena
Respondent
Lorcom Thirteen (Pty) Ltd
Respondent
Frederick Woest Edwards N.O.
Respondent
Companies and Intellectual Property Commission
Respondent
Procedural Posture
Review Application / Judgment
Legal Issues
- 1 Whether the appointment of the first respondent as director of the third respondent was valid in light of failure to notify all shareholders of the meeting.
- 2 Whether the resolution to remove the applicant as director of the third respondent was valid given the procedural requirements of the Companies Act.
- 3 Whether the applicant should be declared a delinquent director or placed under probation under section 162 of the Companies Act.
Ratio Decidendi
The court found that the failure to notify Millivent 24CC, a shareholder, of the 28 October 2021 meeting rendered the resolution appointing the first respondent as director of the third respondent invalid. Section 62 of the Companies Act requires notice to all shareholders, and no waiver or ratification occurred. The subsequent resolution to remove the applicant as director was also invalid, as the applicant was not afforded a reasonable opportunity to respond in person, contrary to section 71(4) of the Companies Act. The respondents' reliance on estoppel was rejected, as estoppel cannot cure non-compliance with statutory requirements enacted in the public interest. The...
Court Disposition
The application was granted; the resolutions appointing the first respondent as director and removing the applicant as director were declared null and void. The counter-application was dismissed. Costs were awarded against the first and second respondents.
Orders
- The resolution dated 28 October 2021 appointing the first respondent as director of the third respondent is declared null and void and of no force and effect.
- The resolution taken by the first and second respondents on 6 May 2022 to remove the applicant as director of the third respondent is declared null and void and of no force and effect.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment